BPG is committed to discovery and dissemination of knowledge
Retrospective Study
©The Author(s) 2025.
World J Clin Oncol. Sep 24, 2025; 16(9): 109182
Published online Sep 24, 2025. doi: 10.5306/wjco.v16.i9.109182
Table 1 Descriptive statistics and clinical features of the entire study population are summarized, n (%)
Descriptive and clinical features

Age group, median (IQR)44 (10)
21-305 (3.8)
31-4043 (32.8)
41-5083 (63.4)
Sex
Male70 (53.4)
Female61 (46.6)
Survey (month), median (IQR)44.5 (44.7)
Tumor diameter (cm), median (IQR)5 (2.5)
Multiple colorectal tumor
Negative127 (96.9)
Positive4 (3.1)
Right colon and transvers colon
Negative81 (60.0)
Positive54 (40.0)
Left colon and sigmoid colon
Negative90 (66.6)
Positive45 (33.3)
Rectosigmoid colon and rectum
Negative99 (73.3)
Positive36 (26.6)
Differentiation degree
Well and moderately106 (81.5)
Poor24 (18.5)
Adenocarcinoma component in the tumor
Negative6 (4.6)
Positive125 (95.4)
Musinous component in the tumor
Negative92 (70.2)
Positive39 (29.8)
Signet-ring cell carcinoma component in the tumor
Negative122 (93.1)
Positive9 (6.9)
Lymphovascular invasion
Negative73 (55.7)
Positive58 (44.3)
Perineural invasion
Negative90 (68.7)
Positive41 (31.3)
Recurrens1
Negative103 (78.6)
Positive28 (21.4)
2nd tumor
Negative120 (91.6)
Positive11 (8.4)
Family history
Negative44 (52.4)
Positive40 (47.6)
LN invasion
Negative73 (56.5)
Positive58 (43.5)
T stage
T11 (0.8)
T29 (6.9)
T381 (61.8)
T4a ve T4b40 (30.5)
N stage
N064 (48.9)
N1a, N1b ve N1c40 (30.5)
N2a ve N2b27 (20.6)
Metastasis
Negative99 (75.6)
Positive32 (24.4)
Stage
18 (6.1)
248 (37.4)
343 (32.8)
432 (23.7)
Number of positive LNs, median (IQR)0 (3)
Number of LNs removed, median (IQR)20.5 (17)


Write to the Help Desk